B2M overexpression correlates with malignancy and immune signatures in human gliomas

Because of the limited treatment strategy of gliomas, the key of diagnosis and treatment is finding new molecular biomarkers. Here, we explored the potential of β2-microglobulin (B2M) to serve as a hopeful candidate for immunotherapy or diagnostic biomarker in gliomas. The genomic profiles, clinical...

Full description

Saved in:
Bibliographic Details
Published in:Sci Rep
Main Authors: Zhang, Hao, Cui, Biqi, Zhou, Yulai, Wang, Xinxing, Wu, Wantao, Wang, Zeyu, Dai, Ziyu, Cheng, Quan, Yang, Kui
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930032/
https://ncbi.nlm.nih.gov/pubmed/33658560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84465-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items